Which medication class is often indicated for mild persistent asthma?

Inhaled corticosteroids are the first-line treatment for patients with mild persistent asthma. These medications work by reducing inflammation in the airways, which is a critical component in managing asthma symptoms and preventing exacerbations. Inhaled corticosteroids help to decrease airway hyperresponsiveness and improve lung function by reducing swelling and mucus production, thus allowing for better airflow.

When considering the management of mild persistent asthma, inhaled corticosteroids have been shown to be more effective and safer than other classes of medications for long-term control. They are intended for daily use, which aligns with the need for ongoing management in patients who experience symptoms more than twice a week but are well controlled with their rescue inhalers (short-acting beta-agonists) for occasional acute symptoms.

Other options, such as beta agonists, may provide quick relief of symptoms but do not address the underlying inflammation associated with asthma. Oral steroids are typically reserved for more severe exacerbations due to their side effects with long-term use. Antihistamines are helpful for allergic reactions but do not have a direct role in managing asthma.

Therefore, inhaled corticosteroids are the correct choice for managing mild persistent asthma due to their efficacy in controlling chronic symptoms and reducing inflammation within the airways.